CrushSCI.com
178.3Average days
167.5Median days
71Fastest days
314Longest days
312025 publications

Paper Review Records

All Paper Review Records

10 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

222 days

Arylpiperazine Derivative NAF19 Inhibits Prostate Cancer Activity and Its Molecular Mechanisms

Authors
Hua Jiang; Mingzhen Xu; Songsong Jiang; Weiqiang HuangShow moreShow less
Affiliations
1. Department of Urology, The Fifth Affiliated Hospital of Zunyi Medical University (Zhuhai Sixth People’s Hospital), Zhuhai, China; 2. The Department of Biological and Pharmaceutical Sciences, Zhuhai Campus of Zunyi Medical University, Zhuhai, ChinaShow moreShow less
Source PDF DOI Publisher page
100 days

Treatment Outcomes with Lanadelumab Every 2 Weeks and Garadacimab are Very Similar in Patients with Hereditary Angioedema

Authors
Irmgard Andresen; Natalie Khutoryansky; Sarah L. Feeny; Alissa DangelShow moreShow less
Affiliations
1. Takeda Pharmaceuticals International AG, Zurich, Switzerland; 2. Takeda Development Center Americas, Inc., Lexington, USA; 3. Takeda Pharmaceuticals USA, Inc., Cambridge, USAShow moreShow less
Source PDF DOI Publisher page
314 days

The Influence of Renal or Hepatic Impairment on the Pharmacokinetics of Iclepertin (BI 425809): Results from Two Phase I Open-Label, Non-randomised, Single Dose, Parallel Design Studies

Authors
HeeJae Choi; Shilpa Madari; Elmar Daalman; Brett A. English; Atef Halabi; Kathrin Hohl; Yury Shatillo; Nathalie Weidinger; Michael DeschShow moreShow less
Affiliations
1. Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, USA; 2. Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany; 3. CRS Clinical Research Services Kiel GmbH, Kiel, GermanyShow moreShow less
Source PDF DOI Publisher page
187 days

Advanced Drug Delivery Strategies for Overcoming Biological Barriers: Tumor Microenvironment and Blood–Brain Barrier

Authors
Yicong Lei; Tingyu Xiao; Xin Hu; Huaqing LinShow moreShow less
Affiliations
1. Key laboratory for Advanced Drug Delivery Systems of Guangdong Province, Guangdong Pharmaceutical University, Guangzhou, People’s Republic of ChinaShow moreShow less
Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review62 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at [email protected]

Enter your email address so we can reply. Your details will remain private.